Gadolinium Contrasting Agent

by Administrator 20. September 2007 10:09
Gadolinium is an excellent contrasting agent used for MRIs especially for diagnosing malignant breast tumors. When injected, this contrast agent enters into the bloodstream. This FDA approved contrast agent highlights tissues that are normal and tissue that are abnormal in the brain and in the body. Gadolinium causes the abnormal tissue to become brighter and therefore, easy to read on an MRI scan. Gadolinium also aids in locating a tumor that is very small.

There are side effects to using a gadolinium-based contrasting agent. They could include a mild headache, nausea and local pain. But the real issue is with the adverse effects that recent studies have shown gadolinium can produce. The FDA is now warning patients that have issues with their kidneys. These patients have a high risk of developing the debilitating, sometimes fatal disease called nephrogenic systemic fibrosis (NSF). The FDA has also requested that manufactures of contrast agents that contain gadolinium, to include detailed warnings on their labels.

If you have had health issues after undergoing an MRI that used a gadolinium-based contrast agent, speak with a gadolinium lawyer. By calling Williams Kherkher at (866) 950-9000, you can schedule a free consultation with a gadolinium attorney.

Be the first to rate this post

  • Currently 0/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5

Tags:

Comments

Powered by BlogEngine.NET 1.4.5.0

BlogRoll

Download OPML file OPML

home  |  about the firm  |  attorneys  |  nsf/nsd  |  gadolinium  |  articles  |  contact us  |  blog  |  resources  |  link exchange
© Copyright 2004-2012 Williams Kherkher. Attorneys are licensed only in the state of Texas unless otherwise indicated in the biographical section. Past performance is no guarantee of future results. Williams Kherkher's primary office is located in Texas. Terms of Use. Disclaimer.
8441 Gulf Freeway, Suite 600, Houston, TX 77017-5051 -- 800-696-5341

Search Engine Optimization provided by The Search Engine Guys.